| scholarly article | Q13442814 |
| P50 | author | J Luis Espinoza | Q82212990 |
| Akiyoshi Takami | Q60971614 | ||
| P2093 | author name string | Shinichiro Okamoto | |
| Yoshihisa Kodera | |||
| Shigeki Ohtake | |||
| Takahiro Fukuda | |||
| Shinji Nakao | |||
| Yasuo Morishima | |||
| Hideki Akiyama | |||
| Koichi Miyamura | |||
| Yoshinobu Kanda | |||
| Hiroshi Sao | |||
| Makoto Onizuka | |||
| Masami Inoue | |||
| Japan Marrow Donor Program | |||
| P2860 | cites work | Competing risk analysis using R: an easy guide for clinicians | Q80466908 |
| NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism | Q80583273 | ||
| Transforming growth factor-beta1 codon 10 polymorphism is associated with acute GVHD after allogenic BMT in Iranian population | Q80883285 | ||
| Association of autoimmune disease-related gene polymorphisms with chronic graft-versus-host disease | Q81294363 | ||
| NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation | Q81508180 | ||
| Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and its severity after allogeneic transplantation | Q81556688 | ||
| An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation | Q81670916 | ||
| Influence of polymorphism within the heme oxygenase-I promoter on overall survival and transplantation-related mortality after allogeneic stem cell transplantation | Q82006501 | ||
| Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance | Q82193347 | ||
| Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination | Q82312167 | ||
| Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants | Q29619458 | ||
| Estimation of failure probabilities in the presence of competing risks: new representations of old estimators | Q33594562 | ||
| Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population | Q33928216 | ||
| The role of the NKG2D immunoreceptor in immune cell activation and natural killing | Q34142062 | ||
| Roles of the NKG2D immunoreceptor and its ligands | Q34267094 | ||
| Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. | Q34621964 | ||
| Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation | Q35795227 | ||
| Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. | Q35847425 | ||
| Genetic polymorphisms predicting the outcome of bone marrow transplants | Q35964779 | ||
| Physiological roles of murine DAP10 adapter protein in tumor immunity and autoimmunity | Q36652177 | ||
| The NKG2D receptor: immunobiology and clinical implications. | Q37056344 | ||
| Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation | Q37130676 | ||
| Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time | Q38472178 | ||
| 1994 Consensus Conference on Acute GVHD Grading | Q39513397 | ||
| Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation | Q40516766 | ||
| Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation | Q43808864 | ||
| Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program | Q44216272 | ||
| Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation | Q44241092 | ||
| Opposite impact of NKG2D genotype by lifestyle exposure to risk of aerodigestive tract cancer among Japanese | Q44320496 | ||
| Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. | Q44848328 | ||
| The impact of methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism on transplant-related variables after allogeneic hematopoietic cell transplantation in patients receiving MTX as GVHD prophylaxis | Q46512721 | ||
| In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid | Q47596252 | ||
| Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. | Q53449569 | ||
| Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. | Q54684597 | ||
| Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese | Q57918603 | ||
| Effects of HLA Allele and Killer Immunoglobulin-Like Receptor Ligand Matching on Clinical Outcome in Leukemia Patients Undergoing Transplantation With T-cell–Replete Marrow From an Unrelated Donor | Q57918697 | ||
| High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism | Q57918712 | ||
| Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation | Q58814344 | ||
| Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation | Q59055770 | ||
| Allelic discrimination using fluorogenic probes and the 5' nuclease assay | Q74618454 | ||
| IL2 and TNFA gene polymorphisms and the risk of graft-versus-host disease after allogeneic haematopoietic stem cell transplantation | Q79897786 | ||
| P433 | issue | 10 | |
| P921 | main subject | bone marrow | Q546523 |
| P304 | page(s) | 1427-1434 | |
| P577 | publication date | 2009-10-01 | |
| P1433 | published in | Haematologica | Q5638209 |
| P1476 | title | NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies | |
| P478 | volume | 94 |
| Q41070167 | A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation. |
| Q37519488 | A functional polymorphism in the NKG2D gene modulates NK-cell cytotoxicity and is associated with susceptibility to Human Papilloma Virus-related cancers. |
| Q83156114 | A single nucleotide polymorphism of IL-17 gene in the recipient is associated with acute GVHD after HLA-matched unrelated BMT |
| Q84074302 | A single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies |
| Q37907929 | Clinical significance of the HLA-E and CD94/NKG2 interaction |
| Q89719591 | Donor Heme Oxygenase-1 Promoter Gene Polymorphism Predicts Survival after Unrelated Bone Marrow Transplantation for High-Risk Patients |
| Q37734489 | Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes |
| Q34008970 | Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies. |
| Q36662017 | Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies |
| Q34489980 | Genetics, genomics, and evolutionary biology of NKG2D ligands |
| Q37810124 | Genomic polymorphisms of the innate immune system and allogeneic stem cell transplantation. |
| Q41840058 | Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions |
| Q49595021 | Impact of MICA and NKG2D polymorphisms in HLA-fully matched related and unrelated hematopoietic stem cell transplantation |
| Q28066573 | Impact of the MICA-129Met/Val Dimorphism on NKG2D-Mediated Biological Functions and Disease Risks |
| Q57818274 | Infection Complications in Hematopoietic Stem Cells Transplant Recipients: Do Genetics Really Matter? |
| Q49693642 | Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis |
| Q34131549 | Interleukin 10 decreases MICA expression on melanoma cell surface |
| Q37667362 | MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome? |
| Q92702533 | NKG2D Polymorphism in Melanoma Patients from Southeastern Spain |
| Q38631124 | NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib. |
| Q37721591 | Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation. |
| Q40399586 | Peginterferon Alfa-2a/Ribavirin treatment efficacy in chronic hepatitis C patients is related to natural killer group 2D gene rs1049174 GC polymorphism. |
| Q53829699 | Polymorphisms in genes coding for the NK-cell receptor NKG2D and its ligand MICA in recurrent miscarriage. |
| Q60917069 | Recipient Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy |
| Q38623211 | Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant |
| Q38129337 | Role of non-HLA gene polymorphisms in graft-versus-host disease. |
| Q49221858 | Sensing Bacterial-Induced DNA Damaging Effects via Natural Killer Group 2 Member D Immune Receptor: From Dysbiosis to Autoimmunity and Carcinogenesis |
| Q92129677 | The Host-Microbe Interplay in Human Papillomavirus-Induced Carcinogenesis |
| Q36278732 | The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation |
| Q64115110 | The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance |
| Q37853569 | The role of natural killer cells in hematopoietic stem cell transplantation. |
| Q40628153 | Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies |
| Q40209654 | Toll-like receptor genetic variations in bone marrow transplantation. |
Search more.